Literature DB >> 9914445

Effects of tetanus toxin on functional inhibition after injection in separate cortical areas in rat.

G Hagemann1, M Hoeller, C Bruehl, M Lutzenburg, O W Witte.   

Abstract

Tetanus Toxin is widely used as a model of chronic focal epilepsy and is assumed to act by blocking neurotransmitter release with high selectivity for inhibitory synapses. However, the exact mechanisms are not fully understood, since, e.g., GABA release is only temporarily decreased although epileptiform activity persists pointing towards a change in the interplay of excitation and inhibition. Furthermore there have been reports about different effects of tetanus toxin after injection in separate brain areas. Therefore, we investigated the functional inhibition after injecting tetanus toxin either in the motor or sensory cortex of adult rats by using a paired-pulse paradigm as a measure of excitatory and inhibitory drive. Tetanus toxin injection into the motor cortex (n=10) induced a marked, long-lasting reduction in inhibition which was highly significant in most parts of the injected cortical area. Injections into the sensory cortex, however, showed less marked changes in inhibition which were more widespread and significant only in 3 of 14 animals injected. These results give further evidence for a prominent effect of tetanus toxin on functional inhibition and strengthen the idea of a differential effect in separate cortical areas. They may be accounted for by the different cytoarchitecture of cortical areas with variable inhibitory and excitatory intracortical connections. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9914445     DOI: 10.1016/s0006-8993(98)01293-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model.

Authors:  Asante Hatcher; Kwanha Yu; Jochen Meyer; Isamu Aiba; Benjamin Deneen; Jeffrey L Noebels
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 2.  Gene therapy in epilepsy-is it time for clinical trials?

Authors:  Dimitri M Kullmann; Stephanie Schorge; Matthew C Walker; Robert C Wykes
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

3.  Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.

Authors:  Robert C Wykes; Joost H Heeroma; Laura Mantoan; Kaiyu Zheng; Douglas C MacDonald; Karl Deisseroth; Kevan S Hashemi; Matthew C Walker; Stephanie Schorge; Dimitri M Kullmann
Journal:  Sci Transl Med       Date:  2012-11-12       Impact factor: 17.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.